Cargando…
Remimazolam versus propofol for deep sedation/anaesthesia in upper gastrointestinal endoscopy in elderly patients: A multicenter, randomized controlled trial
BACKGROUND AND OBJECTIVE: Propofol is the most commonly used sedative in gastrointestinal endoscopic procedures, but is associated with cardiorespiratory suppression, particularly in elderly patients. Remimazolam is a new short‐acting GABA(A) receptor agonist with minimal impact on cardiorespiratory...
Autores principales: | Lu, Kejian, Wei, Shanshan, Ling, Wenwen, Wei, Yanxia, Ran, Xuelian, Huang, Huageng, Wang, Meixu, Wei, Ning, Liao, Yanying, Qin, Zailing, Pan, Meitao, Wei, Qimei, Fu, Liuhui, Xiong, Boquan, Ma, Chendong, Jiang, Jun, Huang, Yanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100088/ https://www.ncbi.nlm.nih.gov/pubmed/36334013 http://dx.doi.org/10.1111/jcpt.13797 |
Ejemplares similares
-
Remimazolam versus propofol for procedural sedation: a meta-analysis of randomized controlled trials
por: Chang, Yu, et al.
Publicado: (2023) -
Remimazolam Tosylate Combined with Low-Dose Propofol Improves Sedation and Safety in Hysteroscopy
por: Zhang, Fan, et al.
Publicado: (2022) -
Determination of the 50% and 95% Effective Dose of Remimazolam Combined with Propofol for Intravenous Sedation During Day-Surgery Hysteroscopy
por: Tan, Hua, et al.
Publicado: (2023) -
Remimazolam for Sedation During Upper Gastrointestinal Endoscopy in an Adolescent
por: Garrett, Alexandrea, et al.
Publicado: (2022) -
Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study
por: Tang, Yun, et al.
Publicado: (2023)